Coleman RL
No ORCID on file
· 8 papers in corpus
· active 2003-2026
Study types
- article 1
- other 1
- review 1
Condition tags
- endometriosis 3
Top journals
- Gynecologic oncology 2
- Gynecologic oncology research and practice 1
- International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 1
- Journal of biomedicine & biotechnology 1
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1
Frequent coauthors
- Robert L. Coleman 3
- Monk BJ 3
- Slomovitz BM 3
- Brian M. Slomovitz 3
- Bogani G 2
- Amant F 2
- Chiappa V 2
- Abrão MS 2
- Bradley J Monk 2
- Ainhoa Madariaga 2
article
2026
review
2026
OBJECTIVE: To critically evaluate the evidence linking endometriosis to ovarian cancer, with particular focus on endometrioid and clear cell histologic subtypes, and to inform risk stratification and patient counseling. METHODS: A systemat…
2019
BackgroundSecondary surgical cytoreduction in women with platinum-sensitive, recurrent epithelial ovarian, primary peritoneal, or fallopian-tube ("ovarian") cancer is widely practiced but has not been evaluated in phase 3 investigation.Meth…
2018
ObjectiveEstablishing an accurate histologic diagnosis is essential for determining the appropriate course of therapy for ovarian cancer. This study sought to investigate and describe nonovarian cancer pathologies discovered during the syst…
other
2015
PURPOSE: The phosphoinositol-3 kinase (PI3K) pathway is frequently dysregulated in endometrial cancer (EC). Hormonal manipulation leads to response in some patients with EC, but resistance derived from PI3K pathway activation has been docum…
2015
PurposeCompared to other subtypes of epithelial ovarian cancer, clear cell carcinoma of the ovary bears an ominous reputation for chemotherapy resistance, increased relapse rate, and diminished survival. Among patients with distinct histopa…
2013
The natural history of ovarian cancer continues to be characterized by late-stage presentation, metastatic bulky disease burden and stagnant mortality statistics, despite prolific drug development. Robust clinical investigation, particularl…
2003
Recent reports from our laboratory and others support the SELDI ProteinChip technology as a potential clinical diagnostic tool when combined with $n$ -dimensional analyses algorithms. The objective of this study was to determine if the comm…